CP and COVID-19: In this work, we prepared a VP-IVIg from plasma of donors immunized with the BNT162b2 (Pfizer-BioNTech) anti-COVID-19 vaccine and compared its in vitro efficacy and safety with those of a similar CP-IVIg formulation.